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Abstract 
Prevalence of chronic pain and health care costs have caused an escalation of opioid dependency. The 
current national crisis involving opioid dependency and drug overdose are growing problems that need to 
be addressed. Since 2000, there has been an increased awareness of pain relief; more people are looking 
at alternative ways to induce pain relief and stricter guidelines in prescription of addictive opioid 
medications (Manchikanti et al., 2012). Despite growing efforts, opioid use and dependency has risen 
dramatically in the past few years; since 1999, there has been an increase in the number of opioids sold 
and opioid-related deaths in the USA (Manchikanti et al., 2012). Opioid misuse is the leading cause of 
accidental overdose and death (Compton & Volkow, 2006). In 2015, more than 40% of the world’s supply 
of thebaine, the main ingredient in hydrocodone and oxycodone, two forms of opioids, was consumed by 
the USA (Hedegaard et al., 2017). In 2008 there were 36,450 drug overdose deaths and 14,800 of those 
deaths were related to opioid pain relievers (CDC, 2011). By 2017 there were a total of 70,237 drug 
overdose deaths in the USA (Hedegaard et al., 2017). While short term use of opioids has benign effects, 
long-term usage has meaningful effects on rates of abuse or addiction (Compton & Volkow, 2006). It is 
estimated that over 4.3 million US adults are taking opioids regularly in any given week; opioids are one of 
the most widely prescribed class of drugs in the US based on a nationally-representative telephone survey 
(Parsells et al., 2008). 
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Background & Opioid Prevalence 
Prevalence of chronic pain and health care costs have caused an escalation of opioid 
dependency. The current national crisis involving opioid dependency and drug overdose are 
growing problems that need to be addressed. Since 2000, there has been an increased awareness 
of pain relief; more people are looking at alternative ways to induce pain relief and stricter 
guidelines in prescription of addictive opioid medications (Manchikanti et al., 2012).  Despite 
growing efforts, opioid use and dependency has risen dramatically in the past few years; since 
1999, there has been an increase in the number of opioids sold and opioid-related deaths in the 
USA (Manchikanti et al., 2012). Opioid misuse is the leading cause of accidental overdose and 
death (Compton & Volkow, 2006). In 2015, more than 40% of the world’s supply of thebaine, 
the main ingredient in hydrocodone and oxycodone, two forms of opioids, was consumed by the 
USA (Hedegaard et al., 2017). In 2008 there were 36,450 drug overdose deaths and 14,800 of 
those deaths were related to opioid pain relievers (CDC, 2011).  By 2017 there were a total of 
70,237 drug overdose deaths in the USA (Hedegaard et al., 2017). While short term use of 
opioids has benign effects, long-term usage has meaningful effects on rates of abuse or addiction 
(Compton  & Volkow, 2006). It is estimated that over 4.3 million US adults are taking opioids 
regularly in any given week; opioids are one of the most widely prescribed class of drugs in the 
US based on a nationally-representative telephone survey (Parsells et al., 2008). 
Despite the recent research into opioid addiction, and other serious side effects that it 
may cause, opioid use has continued to increase in the USA; more than 3% of persons 70 years 
and older are regular users of opioids (Parsells et al., 2008). The reason for the continued 
prevalence is because opioids are commonly used as an analgesia in medical practice. Some 
patients that use opioids to relieve pain may require higher and higher doses and so these few 
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individuals exposed to opioids chronically will develop addiction over the course of pain 
management (Chia et al., 1999 & Eitan et al., 2017).  In a randomized clinical trial involving the 
analgesic effect of fentanyl, one type of opioid, they found that acute fentanyl tolerance develops 
after administration of high doses during surgery and thus patients reported higher pain intensity 
and required greater fentanyl consumption (Chia et al., 1999).  However, higher doses may not 
necessarily increase pain relief; there is no clear correlation between higher opioid dosage and 
clinical benefits (Chen et al., 2013; Gatti et al., 2013; Vondrackova et al., 2008). One study 
found that there was no true relationship between higher opioid doses and clinical pain scores 
(Chen et al., 2013). In fact, several studies done with oxycodone, another opioid, has found that 
lower doses of the opioid in combination with naloxone, an opioid antagonist, has better chronic 
pain treatment outcomes (Gatti et al., 2013; Vondrackova et al., 2008). There has been increasing 
research in replacing opioids with other drugs or other treatments that are more effective in 
providing pain management and can reduce the various complications that come with opioid 
usage (Forouzan et al., 2019; Law et al., 2017 Radhakrishnan & Sluka, 2005;Vance et al., 2014; 
Walley et al., 2013; Weiss & Rao, 2017).  
Opioid Effects on Various Organ Systems 
Despite increased use of opioids for long term pain management, there are large gaps in 
understanding the efficiency and side effects of opioids. There is now more research being done 
on these adverse side effects and studies are finding that patients that take opioids chronically as 
a form of therapy face adverse effects on various organ systems, including respiratory, 
gastrointestinal, musculoskeletal, cardiovascular, endocrine, and central nervous system   
 (Carman et al., 2011; Longstreth et al., 2006; Mogri et al., 2009; Rajagopal et al., 2004; Stewart 
& Owen, 2013; Walker et al., 2007). Many patients on opiate therapy experience constipation, 
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functional bowel disorders, and nausea (Longstreth et al., 2006). Chronic opioid use can also be 
associated with sleep apnea and ataxic breathing (Mogri et al., 2009; Walker et al., 2007). A 
large study found that there were increased risks of myocardial infarction and cardiovascular 
revascularization among patients using opioids chronically relative to the general population 
(Carman et al., 2011). Chronic opioid usage has an impact on the male and female endocrine 
system as well; in one study males, who survived cancer and are chronically dependent on 
consuming opioids, experienced hypogonadism (Rajagopal et al., 2004). The focus of this paper 
will be on the negative effects of opioids on the musculoskeletal system and the mechanisms 
behind these effects.  
Opioids & Musculoskeletal System: Understanding the Increased Rates of Fractures 
Chronic opioid use can be damaging to the musculoskeletal system, for instance, chronic 
opioid dependence is associated with increased fracture risk according to multiple cohort studies 
(Guo et al., 1998; Li et al., 2013; Saunders et al., 2010; Shorr et al., 1992; Spector et al., 2007; 
Stewart & Owen, 2013; Vestergaard, Rejnmark, & Mosekilde, 2006). Studies focused on older 
adult populations, find that opioid prescriptions like codeine or propoxyphene tend to lead to 
increased rates of hip fractures (Guo et al., 1998; Kamal, Stuart & Beers, 2006; Li et al., 2013; 
Shorr et al., 1992). In a study done on 4,500 residents of Saskatchewan, Canada, who were 65 
years or older, the risk of a fracture was 1.6 times greater for current users of codeine or 
propoxyphene compared to nonusers (Shorr et al., 1992). Concurrent users of both prescriptions 
and other psychotropic drugs were 2.6 times more likely to sustain a fracture injury than 
nonusers of either drug class (Shorr et al., 1992). Similar results were found in another study on 
just propoxyphene that correlated increased fracture rates and opioid usage among older adults 
(Kamal, Stuart & Beers, 2006). Similar studies done on morphine, fentanyl, methadone, 
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oxycodone, nicomorphine, ketobemidone, tramadol, and codeine found that all were associated 
with increased fracture rates attributed to central nervous system effects (Vestergaard, Rejnmark, 
& Mosekilde, 2006).  
Clinical trials have suggested that the opioids have acute effects on the central nervous 
system including cognitive impairment, sedation, and dizziness all of which causes elevated risk 
of falls and fractures (Guo et al., 1998; Li et al., 2013; Vestergaard, Rejnmark, & Mosekilde, 
2006). The importance of opioid prescription in managing pain requires a better understanding of 
opioid drugs and the side effects these drugs have on overall health so clinicians can weigh out 
the benefits and harms of prescribing this class of drugs. It is also important to consider the type 
of opioid prescribed because codeine and propoxyphene were correlated with increased fracture 
risks higher than other opioids like morphine (Li et al., 2013). The dosage is also important to 
consider because higher opioid doses that were greater than or equal to 50 mg a day were 
associated with a 2.00 increase in risk of fractures whereas lower doses did not have as high of a 
risk (Saunders et al., 2010). The mechanism in which opioids affect the central nervous system is 
through the specific binding receptors.  
Cognitive effects of Opioids and the Specific Binding Receptors  
Opioids, drugs that stimulate opioid receptors, induce adverse effects on the central 
nervous system, that can be divided into three groups. The first group includes effects that lower 
the level of consciousness-sedation, drowsiness and sleep disturbance. The second group affects 
the thinking process and includes psychomotor impairment, delirium, hallucinations, dreams and 
nightmares. The third group is of the direct toxic effects of opioids on neurons (Jane, 2007). 
Patients that receive long term chronic opioid therapy often discontinue due to adverse cognitive 
effects including memory deficits, sleep disturbance, and fatigue (Dhingra et al., 2015). 
Observing the adverse side effects of opioids on patients that take pain medication and the 
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various effects of different opioids and the receptors that they bind to, became an area under 
intense research. Gene coding and brain mapping revealed the three opioid peptide systems that 
were responsible for the effects and addictiveness of various opiate drugs, these three receptors 
were (µ ) MOR, (κ)  KOR, and (δ) DOR (Valentino & Volkow, 2018).  
Opioids interactions with the Mu, Delta, and Kappa Receptors 
 
Opioids act on the opioid system consisting of the three most researched opioid receptors:   
mu, kappa and delta, also known as (µ ) MOR, (κ)  KOR, and (δ) DOR respectively, whose 
receptors are activated by opiates like morphine (Grechko et al., 2017; Guarraci et al., 
2017;Ozaki et al., 1994 ; Shahbazian et al., 2002; Valentino & Volkow, 2018). Opiates have 
interesting effects on contraction in various parts of the body, for instance, they may inhibit 
gastrointestinal propulsion (Shahbazian et al., 2002). Opioids like morphine seem to induce 
inhibition of peristalsis depending on the dosage, with a dose-dependent maximum effect 
observed in the dose of 10 mg/kg in one study (Grechko et al., 2017). Other findings support  
that opiates can cause presynaptic inhibition of excitatory neurotransmission at two sites within 
the wall of the gallbladder: these findings support the concept that opiates can contribute to 
gallbladder stasis by inhibiting ganglion activity and neurogenic contractions (Guarraci et al., 
2017).  
Mu-opioid receptor agonists, kappa-opioid receptor agonists and a delta-opioid receptor 
agonist were studied in one study through guinea pigs. Experiments with the delta-opioid 
receptor antagonists, the kappa-opioid receptor antagonist and the mu-opioid receptor antagonist 
revealed that the inhibitory effects of opiates on involuntary contractions were mediated by 
kappa-opioid receptors and that of morphine through mu-opioid receptors. The results show that 
the neural pathways controlling peristalsis in the guinea-pig small intestine were inhibited by 
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opioids acting via mu- and kappa-, but not delta-, opioid receptors (Shahbazian et al., 2002). 
Similar results were found in another study in isolated guinea-pig ileal longitudinal muscle, using 
selective mu, kappa and delta opioid receptor antagonists where the mu antagonist produced a 
concentration-dependent twitch inhibition (Ozaki et al., 1994). These studies explain why KORs 
have been found to localize to axon terminals and inhibit neurotransmitter release and MOR has 
been found to inhibit norepinephrine, substances important in the ends of nerve fibers that 
increase the force of muscle contraction (Valentino & Volkow, 2018).  
Opioids Inhibit Neurotransmitter Release  
 
Opioids affect various parts of the body, and can inhibit neurotransmitter release from 
different parts of the body inhibiting muscle contractions. Release of norepinephrine, also known 
as noradrenaline, was inhibited in the mouse vas deferens via opiate receptors (Knoll et al., 
1981).  Interestingly, other consecutive studies done on animal species, have found that 
morphine, pethidine, naloxone, N-methylnaloxone, naltrexone and levallorphan seem to inhibit 
muscle contraction mediated via the peripheral opiate binding site (Berggren, Rubenson, & 
Sillen 1992; Ramabadran et al, 1983;  Sim & Chua 1986; Sim & Ramabadran 1983). One study 
found that morphine depresses twitch and tetanus of guinea-pig ileum by reducing acetylcholine 
output from nerve endings (Paton, 1997). 
Different opioids are grouped into different categories suggesting sub-types of binding 
sites in the contraction of skeletal muscle; the classification of the four classes are as follows, 
morphine and naltrexone each formed their own class, naloxone, N-methylnaloxone and 
pethidine formed another class; levallorphan and dextrallorphan formed the fourth class 
(Ramabadran et al, 1983). The significance of each of the sub-types, their binding sites, and how 
they may affect skeletal muscle contraction is still an area under research but based on different 
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animal studies, one way opioids seem to inhibit contraction is through acetylcholine 
(Ramabadran et al, 1983; Sim & Chua, 1986; Sim & Ramabadran, 1983). An interesting study 
done on the toad rectus, found that certain opioids, except morphine, nalorphine and levorphanol, 
inhibit the ACh-induced contraction through multiple modes of action; the opioids inhibit 
competitively indicating that they are able to compete with ACh for cholinergic receptors at the 
nicotinic site (Sim & Ramabadran, 1983). Further research, found that the opioids which are 
poor or non-inhibitors of AChEase, the enzyme that breaks down acetylcholine, are strong 
inhibitors of the ACh-induced contraction of the toad rectus, whereas the reverse is true for 
inhibitors of AChEase (Sim & Chua, 1986). Another study, however, done on fetal vessels of 
human placentae find that only high concentrations of synthetic opioids or opioid antagonists 
reduced ACh output; thus, therapeutic concentrations of morphine and pethidine would not affect 
placental ACh output (Gude et al., 1989). Thus, while we know that opioids affect 
neurotransmitter release in the brain and central nervous system there is still more research to be 
done on whether the inhibition affects contraction of skeletal muscles in humans and the type of 
opioids that may induce these effects.  
Clinical Interventions: Opioids and Naloxone Interactions 
Naloxone, an opioid antagonist, counteracts some of the effects of morphine and causes a 
significant facilitation of the electrical field stimulation-induced contraction, in both rat and 
human detrusor. This suggests that naloxone may be able to counteract some of the inhibitory 
effects of morphine (Berggren, Rubenson, & Sillen 1992). The interactions between these two 
drugs may explain why buprenorphine/naloxone, methadone and lofexidine are medications that 
are often used in the treatment of opiate withdrawal; methadone/lofexidine and 
buprenorphine/naloxone have comparable outcomes and efficiency when treating detoxification 
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in low dose opiate users (Law et al., 2017; Walley et al., 2013; Weiss & Rao, 2017). Naloxone 
and other medications are not the only treatments for opioid dependency under study.  
Clinical Interventions: Transcutaneous Electrical Nerve Stimulation (TENS): therapeutic 
treatment in Replacement of Opioids  
 
Transcutaneous Electrical Nerve Stimulation (TENS), is clinically used as a therapeutic 
mechanism to reduce pain by activating large diameter afferent fibers in order to reduce pain 
(Levin & Hui-Chan, 1993; Radhakrishnan & Sluka, 2005; Vance et al., 2014). TENS produced 
an anti-hyperalgesia effect on induced hyperalgesia in the knee joints of rats, this anti-
hyperalgesia is beneficial in reducing use of other forms of pain relievers like opioids 
(Radhakrishnan & Sluka, 2005). A human study found similar results, and found that TENS 
activated similar peripheral afferent fibers in humans in order to provide an acupuncture-like 
relief from pain (Levin & Hui-Chan, 1993). The reduction of pain through TENS will replace 
other forms of analgesics like opioid drugs that have serious side effects including contraction 
inhibition and addiction.  
Clinical Interventions: Education to Reduce Opioid Dependency  
 Opioid overdose and addiction  is a serious concern for the nation, in order to combat this 
growing problem not only will we need to rely on alternative forms of pain management like 
TENS and other medications like naloxone but the nation must actively provide overdose 
education. In Massachusetts, overdose education and nasal naloxone distribution known as 
OEND programs are utilized and opioid overdose rates were reduced in communities where 
OEND programs were implemented (Walley et al., 2013).  
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Conclusion 
 It is clear that the country is facing a national opioid crisis with rising rates of opioid 
dependency and rising rates of drug overdose deaths (Compton & Volkow, 2006; Manchikanti et 
al., 2012). Opioids have taken over the country with an estimated of over 4.3 million US adults 
taking opioids regularly in any given week; Americans have become dependent on opioid drugs 
for pain relief and these drugs continue to be prescribed daily to more and more people (Parsells 
et al., 2008). Opioids should not be used for long term pain management because of the various 
side effects these class of drugs can induce. There has been increasing research that shows a 
negative impact on overall health and these adverse effects can target various organ systems 
including respiratory, gastrointestinal, musculoskeletal, cardiovascular, immune, endocrine, and 
central nervous system (Carman et al., 2011; Longstreth et al., 2006; Mogri et al., 2009; 
Rajagopal et al., 2004; Stewart & Owen, 2013; Walker et al., 2007). 
Chronic opioid usage has been associated with increased fracture risks according to 
multiple studies and many studies have suggested that opioids cause acute effects on the central 
nervous system including cognitive impairment, sedation, and dizziness which leads to elevated 
risks of falls that lead to increased rates of fractures in patients taking opioids (Guo et al., 1998; 
Li et al., 2013; Vestergaard, Rejnmark, & Mosekilde, 2006). Opioids act on specific opioid 
receptors in the central nervous system that may cause these different effects. The three opioid 
receptors that are commonly discussed in the literature include (µ ) MOR, (κ)  KOR, and (δ) 
DOR (Valentino& Volkow, 2018). 
Opioids like morphine bind to mu receptor and can induce effects in various parts of the 
body and some of these effects include inhibition of contraction. Other findings support that 
opiates cause inhibition of excitatory neurotransmitters or inhibit twitches (Guarraci et al., 2017; 
Ozaki et al., 1994 ; Shahbazian et al., 2002). Morphine and other opioids seem to inhibit muscle 
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contraction through inhibition of acetylcholine according to a few studies (Berggren, Rubenson, 
& Sillen 1992; Ramabadran et al, 1983;  Sim & Chua 1986; Sim & Ramabadran 1983). 
However, these results are not conclusive and there has been no human clinical trials but the 
research into opioids and their binding sites is still ongoing because there is still a lot the 
scientific community doesn’t know about opioids.  
While we may not know everything about opioids, the country is still facing an opioid 
epidemic. There is no single solution to the opioid crisis, but action needs to be taken 
now because as the death toll rises and opioids claim more lives patients are still being 
prescribed opioid medications. Some of these patients may take these drugs without fully 
understanding the adverse effects opioids have on overall health. Naloxone, may be one solution 
because this drug can counteract some of the effects of morphine and can be used in the 
treatment of opioid withdrawal or detoxification (Law et al., 2017; Walley et al., 2013; Weiss & 
Rao, 2017). Other solutions may be to prevent opioid dependency in the first place through 
educational reform that has proven to be effective for Massachusetts (Walley et al., 2013). 
Replacing opioid medication with other forms of analgesics may also be an option, TENS, for 
instance is one such clinical practice being used to relieve pain (Levin & Hui-Chan, 1993; 
Radhakrishnan & Sluka, 2005). As further research continues on opioids, their adverse effects on 
health, and the receptors that they bind to causing inhibition of normal function, action needs to 
be taken to reverse the growing number of opioid overdose deaths and addicts. 
 
 
 
 
Adverse	Effects	of	Opioid	Dependency	on	Central	and	Peripheral	Aspects	of	the	Neuromuscular	
System,	Yang	
11	
	
Bibliography 
Berggren, A., Rubenson, A., & Sillén, U. (1992, September). Involvement of opioid  
 mechanisms in peripheral motor control of detrusor muscle. Retrieved from  
 https://www.ncbi.nlm.nih.gov/pubmed/1279654. 
Carman, W. J., Su, S., Cook, S. F., Wurzelmann, J. I., & McAfee, A. (2011, July).   
 Coronary heart disease outcomes among chronic opioid and cyclooxygenase-2  
 users compared with a general population cohort. Retrieved from    
 https://www.ncbi.nlm.nih.gov/pubmed/21567652. 
Centers for Disease Control and Prevention (CDC). (2011, November 4). Vital signs:   
 overdoses of prescription opioid pain relievers---United States, 1999--2008.  
 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22048730.  
Chen L, Vo T, Seefeld L, Malarick C, Houghton M, Ahmed S, et al. Lack of correlation  
 between opioid dose adjustment and pain score change in a group of chronic pain  
 patients. J Pain. 2013;14: 384–392. pmid:23452826 
Chia Y-Y, Liu K, Wang J-J, Kuo M-C, Ho S-T. Intraoperative high dose fentanyl induces  
 postoperative fentanyl tolerance. Can J Anesth. 1999;46(9):872–7. 
Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United  
 States: concerns and strategies. Drug Alcohol Depend. 2006;81: 103–107.   
 pmid:16023304  
Dhingra, Lara, Ahmed, Shin, Jae, Scharaga, … Maximilian. (2015, October 13).   
 Cognitive Effects and Sedation. Retrieved from      
 https://academic.oup.com/painmedicine/article/16/suppl_1/S37/2472485. 
Eitan, S., Emery, M. A., Bates, M. L. S., & Horrax, C. (2017, December). Opioid   
 addiction: Who are your real friends? Retrieved from     
 https://www.ncbi.nlm.nih.gov/pubmed/28552458.  
Forouzan, A., Masoumi, K., Motamed, H., Esfahani, S. R. N., & Delirrooyfard, A.  
 (2019). Comparison of the Analgesic Effect of Intravenous Ketamine versus  
 Intravenous Morphine in Reducing Pain of Renal Colic Patients: Double-Blind  
 Clinical Trial Study. Retrieved from        
 https://www.ncbi.nlm.nih.gov/pubmed/31284871.  
Gatti, A., Casali, M., Lazzari, M., Tufaro, G., Gafforio, P., Silvestri, C., … Sabato, A. F.  
 (2013, January). Prolonged-release oxycodone/naloxone in nonmalignant pain:  
 single-center study in patients with constipation. Retrieved from    
 https://www.ncbi.nlm.nih.gov/pubmed/23269562. 
Grechko, O. Y., Litvinov, R. A., Spasov, A. A., Rashchenko, A. I., Shtareva, D. M.,  
 Anisimova, V. A., & Minkin, V. I. (2017, March). Study of µ- and δ-Opioid  
 Activities in Agents with Various κ-Receptor Selectivity. Retrieved from   
 https://www.ncbi.nlm.nih.gov/pubmed/28361412. 
Guarraci, F. A., Pozo, M. J., Palomares, S. M., Firth, T. A., & Mawe, G. M. (2002,  
 February). Opioid agonists inhibit excitatory neurotransmission in ganglia and at  
 the neuromuscular junction in Guinea pig gallbladder. Retrieved from   
 https://www.ncbi.nlm.nih.gov/pubmed/11832449.  
Gude, N. M., Krishna, B. R., King, R. G., Brennecke, S. P., & Boura, A. L. (1989).  
 Effects of opioids on acetylcholine output of perfused human placental cotyleda.  
 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/2674931.  
Adverse	Effects	of	Opioid	Dependency	on	Central	and	Peripheral	Aspects	of	the	Neuromuscular	
System,	Yang	
12	
	
Guo, Z., Wills, P., Viitanen, M., Fastbom, J., & Winblad, B. (1998). Cognitive   
 Impairment, Drug Use, and the Risk of Hip Fracture in Persons over 75 Years  
 Old: A Community-based Prospective Study. American Journal of Epidemiology,  
 148(9), 887–892. doi: 10.1093/oxfordjournals.aje.a009714 
Hedegaard H, Warner M, Miniño AM. Drug overdose deaths in the United States,   
 1999-2016. NCHS Data Brief. 2017;294:1–8. 
Jane Vella-Brincat (Medical Director) (Clinical Pharmacist) & A. D.    
 MacLeod (2007) Adverse Effects of Opioids on the Central Nervous Systems of  
 Palliative Care Patients, Journal of Pain & Palliative Care     
 Pharmacotherapy, 21:1, 15-25, DOI: 10.1080/J354v21n01_05 
Kamal-Bahl, S. J., Stuart, B. C., & Beers, M. H. (2006, September). Propoxyphene use  
 and risk for hip fractures in older adults. Retrieved from     
 https://www.ncbi.nlm.nih.gov/pubmed/17062322. 
Knoll, J., Kerecsen, L., Somogyi, G. T., & Kovács, A. (1981, May). Opiate agonists  
 inhibit noradrenaline release via opiate B-receptors and     
 N-cyclopropylmethylnorazidomorphine (CAM) blocks electrically evoked  
 contractions via histamine in the mouse vas deferens. Retrieved from   
 https://www.ncbi.nlm.nih.gov/pubmed/6266359. 
Law, F. D., Diaper, A. M., Melichar, J. K., Coulton, S., Nutt, D. J., & Myles, J. S. (2017,  
 August). Buprenorphine/naloxone versus methadone and lofexidine in community 
 stabilisation and detoxification: A randomised controlled trial of low dose   
 short-term opiate-dependent individuals. Retrieved from     
 https://www.ncbi.nlm.nih.gov/pubmed/28631527. 
Levin, M. F., & Hui-Chan, C. W. (1993, January). Conventional and acupuncture-like  
 transcutaneous electrical nerve stimulation excite similar afferent fibers. Retrieved 
 from https://www.ncbi.nlm.nih.gov/pubmed/8420521. 
Li, L., Setoguchi, S., Cabral, H., & Jick, S. (2013). Opioid Use for Noncancer Pain and  
 Risk of Fracture in Adults: A Nested Case-Control Study Using the General  
 Practice Research Database. American Journal of Epidemiology, 178(4),   
 559–569. doi: 10.1093/aje/kwt013 
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, 
 R. C. (2006, April). Functional bowel disorders. Retrieved from    
 https://www.ncbi.nlm.nih.gov/pubmed/16678561?dopt=Abstract. 
Manchikanti L, Helm SI, Fellows B, Janata JW, Pampati V, Grider JS, et al. Opioid  
 epidemic in the United States. Pain Physician. 2012;15(3):ES9–ES38.  
Mogri, M., Desai, H., Webster, L., Grant, B. J. B., & Mador, M. J. (2009, March).   
 Hypoxemia in patients on chronic opiate therapy with and without sleep apnea.  
 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/18683000. 
Ozaki, M., Miyamoto, Y., Kishioka, S., Masuda, Y., & Yamamoto, H. (1994, May).  
 Participation of opioid receptor types on post-tetanic twitch inhibition in isolated  
 guinea-pig ileal longitudinal muscle. Retrieved from     
 https://www.ncbi.nlm.nih.gov/pubmed/7936103.  
Parsells Kelly J, Cook SF, Kaufman DW, Anderson T, Rosenberg L, Mitchell AA.  
 Prevalence and characteristics of opioid use in the US adult population. Pain.  
 2008;138: 507–513. pmid:18342447 
Adverse	Effects	of	Opioid	Dependency	on	Central	and	Peripheral	Aspects	of	the	Neuromuscular	
System,	Yang	
13	
	
Paton, W. D. (1997, February). The action of morphine and related substances on   
 contraction and on acetylcholine output of coaxially stimulated guinea-pig ileum.  
 Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224282/. 
Radhakrishnan, R., & Sluka, K. A. (2005, October). Deep tissue afferents, but not   
 cutaneous afferents, mediate transcutaneous electrical nerve stimulation-Induced  
 antihyperalgesia. Retrieved from        
 https://www.ncbi.nlm.nih.gov/pubmed/16202960.  
Ramabadran, K., Sim, M. K., & Lun, K. C. (1983, February). Neuromuscular effects of  
 some opioid agonists and antagonists. Retrieved from     
 https://www.ncbi.nlm.nih.gov/pubmed/6308317. 
Rajagopal, A., Vassilopoulou-Sellin, R., Palmer, J. L., Kaur, G., & Bruera, E. (2004,  
 February 15). Symptomatic hypogonadism in male survivors of cancer with  
 chronic exposure to opioids. Retrieved from       
 https://www.ncbi.nlm.nih.gov/pubmed/14770444.  
Saunders, K. W., Dunn, K. M., Merrill, J. O., Sullivan, M., Weisner, C., Braden, J. B., … 
 Von Korff, M. (2010, April). Relationship of opioid use and dosage levels  to 
 fractures in older chronic pain patients. Retrieved from     
 https://www.ncbi.nlm.nih.gov/pubmed/20049546. 
Sim, M. K., & Chua, M. E. (1986, February). Inhibition of acetylcholinesterase by  
 various opioids. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/2940040.  
Sim, M. K., & Ramabadran, K. (1985). Effects of opioids on the ACh-induced   
 contraction of the toad rectus. Retrieved from      
 https://www.ncbi.nlm.nih.gov/pubmed/3002693.   
Shahbazian, A., Heinemann, A., Schmidhammer, H., Beubler, E., Holzer-Petsche, U., &  
 Holzer, P. (2002, February). Involvement of mu- and kappa-, but not delta-, opioid 
 receptors in the peristaltic motor depression caused by endogenous and exogenous 
 opioids in the guinea-pig intestine. Retrieved from      
 https://www.ncbi.nlm.nih.gov/pubmed/11834622.  
Shorr, R. I., Griffin, M. R., Daugherty, J. R., & Ray, W. A. (1992, July). Opioid   
 analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene.  
 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/1624693. 
Stewart, G., & Owen, M. (2013, December 3). Opioids in the management of persistent  
 non-cancer pain. Retrieved from        
 https://www.sciencedirect.com/science/article/pii/S147202991300252X. 
Spector, W., Shaffer, T., Potter, D. E. B., Correa-de-Araujo, R., & Rhona Limcangco, M.  
 (2007, March). Risk factors associated with the occurrence of fractures in U.S.  
 nursing homes: resident and facility characteristics and prescription medications.  
 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/17341233. 
Valentino, R. J., & Volkow, N. D. (2018, December). Untangling the complexity of  
 opioid receptor function. Retrieved from       
 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224460/. 
Vance, C. G. T., Dailey, D. L., Rakel, B. A., & Sluka, K. A. (2014, May). Using TENS  
 for pain control: the state of the evidence. Retrieved from     
 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186747/. 
Adverse	Effects	of	Opioid	Dependency	on	Central	and	Peripheral	Aspects	of	the	Neuromuscular	
System,	Yang	
14	
	
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2006, July). Fracture risk associated with 
 the use of morphine and opiates. Retrieved from      
 https://www.ncbi.nlm.nih.gov/pubmed/16789982. 
Vondrackova, D., Leyendecker, P., Meissner, W., Hopp, M., Szombati, I., Hermanns, K.,  
 … Reimer, K. (2008, December). Analgesic efficacy and safety of oxycodone in  
 combination with naloxone as prolonged release tablets in patients with moderate  
 to severe chronic pain. Retrieved from       
 https://www.ncbi.nlm.nih.gov/pubmed/18708300. 
Walley, A. Y., Xuan, Z., Hackman, H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad,  
 A., … Ozonoff, A. (2013, January 31). Opioid overdose rates and implementation 
 of overdose education and nasal naloxone distribution in Massachusetts:   
 interrupted time series analysis. Retrieved from      
 https://www.bmj.com/content/346/bmj.f174.full. 
Walker, J. M., Farney, R. J., Rhondeau, S. M., Boyle, K. M., Valentine, K., Cloward, T.  
 V., & Shilling, K. C. (2007, August 15). Chronic opioid use is a risk factor for the  
 development of central sleep apnea and ataxic breathing. Retrieved from   
 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1978331/.  
Weiss, R. D., & Rao, V. (2017, April 1). The Prescription Opioid Addiction Treatment  
 Study: What have we learned. Retrieved from      
 https://www.ncbi.nlm.nih.gov/pubmed/28363320. 
 
 
 
 
 
